Previous 10 | Next 10 |
Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Results from Three Clinical Utility Studies PR Newswire Studies demonstrate real-world clinical utility of EsoGuard testing to detect esophageal precancer NEW YORK , Dec. 12, 2023 /PRNewswi...
PAVmed Provides Additional Details for Upcoming Stock Dividend to Shareholders PR Newswire PAVmed shareholders as of January 15, 2024 will participate in distribution of approximately 3.3 million shares of Lucid common stock NEW YORK , Dec. 11, 2023 /...
2023-12-05 08:55:07 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips There are penny stocks and then are penny stock picks that are so outrageously wild that they should never be considered unless one is gambling with pocket change. And by pocket change, I...
2023-12-04 16:32:40 ET More on Lucid Diagnostics, PAVmed, etc. PAVmed Inc. (PAVM) Q3 2023 Earnings Call Transcript Lucid Diagnostics Inc. (LUCD) Q3 2023 Earnings Call Transcript PAVmed Q3 2023 Earnings Preview PAVmed Q3 2023 Earnings Preview Seeking A...
PAVmed Announces Dividend of Lucid Diagnostics Common Stock and Reverse Stock Split PR Newswire PAVmed shareholders as of January 15, 2024 will participate in distribution of approximately 3.3 million shares of Lucid common stock 1-for-15 reverse stock split to be ...
Lucid Diagnostics Strengthens and Expands Market Access and Direct Contracting Efforts PR Newswire Industry veterans join executive team as VP, Market Access and VP, Employer Markets Shaun M. O'Neil promoted to Lucid's President and COO NEW YORK , ...
2023-11-15 19:00:12 ET PAVmed Inc. (PAVM) Q3 2023 Earnings Call Transcript November 15, 2023 08:30 AM ET Company Participants Michael Parks - Vice President of Investor Relations Lishan Aklog - Chairman and Chief Executive Officer Dennis McGrath - Executive Vice ...
2023-11-14 17:57:16 ET More on PAVmed PAVmed Q3 2023 Earnings Preview PAVmed Q3 2023 Earnings Preview Seeking Alpha’s Quant Rating on PAVmed Historical earnings data for PAVmed Financial information for PAVmed For further details see: ...
PAVmed Provides Business Update and Third Quarter Financial Results PR Newswire Lucid's quarterly revenue increased 392 percent sequentially Veris Health commercial expansion efforts underway, with next-generation Veris Cancer Care Platform launching in Q4 Conf...
Lucid Diagnostics Provides Business Update and Third Quarter Financial Results PR Newswire Quarterly EsoGuard ® test volume and revenue increased 17 percent and 392 percent sequentially, respectively Conference call and webcast to be held tomorrow, November ...
News, Short Squeeze, Breakout and More Instantly...
Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume PR Newswire Quarterly EsoGuard ® test volume increased 31 percent sequentially NEW YORK , July 23, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("L...
Lucid Diagnostics Launches New Corporate Website PR Newswire NEW YORK , July 11, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and majority-ow...
Lucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population PR Newswire Prospective screening study demonstrates excellent EsoGuard s...